These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1321402)
1. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells. Chen TM; Defendi V Oncogene; 1992 Aug; 7(8):1541-7. PubMed ID: 1321402 [TBL] [Abstract][Full Text] [Related]
2. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells. Chen TM; Chen CA; Hsieh CY; Chang DY; Chen YH; Defendi V Oncogene; 1993 Jun; 8(6):1511-8. PubMed ID: 8389030 [TBL] [Abstract][Full Text] [Related]
3. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses. Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886 [TBL] [Abstract][Full Text] [Related]
4. The early HPV16 proteins can regulate mRNA levels of cell cycle genes in human cervical carcinoma cells by p53-independent mechanisms. Fogel S; Riou G Virology; 1998 Apr; 244(1):97-107. PubMed ID: 9581783 [TBL] [Abstract][Full Text] [Related]
5. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells. Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117 [TBL] [Abstract][Full Text] [Related]
6. Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor. Steller MA; Zou Z; Schiller JT; Baserga R Cancer Res; 1996 Nov; 56(21):5087-91. PubMed ID: 8895768 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Yuan H; Fu F; Zhuo J; Wang W; Nishitani J; An DS; Chen IS; Liu X Oncogene; 2005 Jul; 24(32):5069-78. PubMed ID: 15856013 [TBL] [Abstract][Full Text] [Related]
8. HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53. Vousden KH; Vojtesek B; Fisher C; Lane D Oncogene; 1993 Jun; 8(6):1697-702. PubMed ID: 8389035 [TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Pim D; Storey A; Thomas M; Massimi P; Banks L Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532 [TBL] [Abstract][Full Text] [Related]
10. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
11. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692 [TBL] [Abstract][Full Text] [Related]
12. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes. Medina-Martínez O; Vallejo V; Guido MC; García-Carrancá A Mol Carcinog; 1997 Jun; 19(2):83-90. PubMed ID: 9210955 [TBL] [Abstract][Full Text] [Related]
13. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Aguilar-Lemarroy A; Gariglio P; Whitaker NJ; Eichhorst ST; zur Hausen H; Krammer PH; Rösl F Oncogene; 2002 Jan; 21(2):165-75. PubMed ID: 11803460 [TBL] [Abstract][Full Text] [Related]
14. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855 [TBL] [Abstract][Full Text] [Related]
15. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150 [TBL] [Abstract][Full Text] [Related]
16. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1. Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882 [TBL] [Abstract][Full Text] [Related]
17. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059 [TBL] [Abstract][Full Text] [Related]
18. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643 [TBL] [Abstract][Full Text] [Related]
19. Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16 E6. Inoue T; Oka K; Yong-Il H; Vousden KH; Kyo S; Jing P; Hakura A; Yutsudo M Mol Carcinog; 1998 Mar; 21(3):215-22. PubMed ID: 9537653 [TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]